During the Zhongshan Medical Retina and Epidemiology Symposium, I was honored to meet Dr. Cheng and invite him for a brief interview to share his expertise on population-based study on glaucoma. First of all, Dr. Cheng briefed us the current statues of population-based study on glaucoma, saying that there are many population-based study conducted in recent 10 years, which gives us a good picture of the epidemiology of glaucoma. “However, there are still challenges in the population-based study”, Dr. Cheng pointed out “One of the biggest challenges is to make good use of the knowledge attained in the population-based study and to apply them to the clinical practice.”

Dr. Cheng also shared with us the advances on genomic technology in the recent decade, such as genowhite, genotyping and next generation sequencing technology. He claimed that these advanced technologies help us better understand diseases determined by genome.

When asked about the urgent task in ophthalmology, Dr. Cheng replied that it depends on the countries. Despite of that, he still thought more research about new treatment of AMD, glaucoma disease and other eye disease should be conducted.
For more details about this interview, readers can refer to the following video (Figure 2). 

Figure 2 Ching-Yu Cheng: current status quo of population-based study on glaucoma ⁽¹⁾.